Amgen's USD200mn investment set to push India's pharmaceutical innovation forward
Deal News | Mar 03, 2025 | fitch media ventures
The article discusses the strategic establishment of technology and innovation centers in India by multinational pharmaceutical companies, highlighting a significant investment by Amgen. This move is part of a broader strategy to utilize India's digital prowess to support global pharmaceutical operations. Hyderabad is emphasized as a burgeoning hub for pharmaceutical innovation due to the presence of companies like Amgen, Eli Lilly, Bristol Myers Squibb, and others. The Telangana government is actively supporting this growth through policies aimed at advancing life sciences capabilities. Despite India's increasing investment in pharmaceuticals, challenges remain, particularly in developing local talent and research infrastructure. The future outlook suggests sustained growth for India's pharmaceutical market, projected to become the third-largest in the APAC region by 2029.
Sectors
- Pharmaceuticals
- Technology and Innovation
Geography
- India – India is the primary focus of the article, highlighting its emerging role as a hub for pharmaceutical innovation and digital capabilities.
- Hyderabad – Hyderabad is specifically mentioned as the location for new technology and innovation centers by companies like Amgen and Eli Lilly.
Industry
- Pharmaceuticals – The article discusses the pharmaceutical sector with a focus on the establishment of innovation centers by global pharmaceutical companies in India.
- Technology and Innovation – The emphasis on technology and innovation centers, digital capabilities, AI, and R&D infrastructure underscores its relevance to the technology sector.
Financials
- USD200mn – The investment amount announced by Amgen for the establishment of a technology and innovation center in Hyderabad.
- INR2.7trn or USD33.3bn – The value of India's pharmaceutical market in 2024.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Amgen | Investor/Buyer | Company | A multinational biopharmaceutical company investing USD200mn in a new technology and innovation center in Hyderabad, India. |
| Eli Lilly | Other Company | Company | A global pharmaceutical company that has established the Lilly Capability Center India in Hyderabad. |
| Fitch Media Ventures | Source | Company | The Private Equity firm that provided insights on strategic investments in India's pharmaceutical sector. |
| Telangana Government | Government | Government | The state government that introduced a new life sciences policy to bolster pharmaceutical growth in the region. |